<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Acta Otorhinolaryngol Ital</journal-id>
      <journal-id journal-id-type="publisher-id">Pacini</journal-id>
      <journal-title-group>
        <journal-title>Acta Otorhinolaryngologica Italica</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0392-100X</issn>
      <issn pub-type="epub">1827-675X</issn>
      <publisher>
        <publisher-name>Pacini Editore SpA</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22064946</article-id>
      <article-id pub-id-type="pmc">3203747</article-id>
      <article-id pub-id-type="publisher-id">Pacini</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">
Subcutaneous sarcoidosis: a rare involvement
of the paralateral nasal region</article-title>
        <trans-title-group xml:lang="it">
          <trans-title>Sarcoidosi sottocutanea: un raro caso di coinvolgimento della regione paralatero
nasale</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>BIANCHINI</surname>
            <given-names>C.</given-names>
          </name>
          <xref ref-type="corresp" rid="COR1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>TOSIN</surname>
            <given-names>E.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>CIORBA</surname>
            <given-names>A.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>PELUCCHI</surname>
            <given-names>S.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>PASTORE</surname>
            <given-names>A.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>ENT Department, University Hospital of Ferrara, Italy</aff>
      <author-notes>
        <corresp id="COR1">
Address for correspondence: Dott.ssa C. Bianchini, Clinica ORL,
Universit&#xE0; di Ferrara, c.so Giovecca 203, 44100 Ferrara, Italy. Fax:
+39 0532 237615. E-mail: <email xlink:href="chiara.bianchini@unife.it">chiara.bianchini@unife.it</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <volume>31</volume>
      <issue>2</issue>
      <fpage>118</fpage>
      <lpage>120</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>5</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>7</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Copyright by Societ&#xE0; Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link></license-p>
        </license>
      </permissions>
      <abstract>
        <title>SUMMARY</title>
        <p>A case of subcutaneous sarcoidosis involving the paralateral nasal region is described and a brief review of the literature is made. Subcutaneous
sarcoidosis without systemic disease is a rare entity and has seldom been reported on the trunk and face. Diagnosis is always difficult
as it can only be confirmed by histological studies.</p>
      </abstract>
      <trans-abstract xml:lang="it">
        <title>RIASSUNTO</title>
        <p>In questo articolo viene descritto un raro caso di sarcoidosi sottocutanea con coinvolgimento della regione paralatero-nasale e viene presentata
una revisione della letteratura sull'argomento. La sarcoidosi sottocutanea senza interessamento sistemico &#xE8; una patologia inusuale,
e ancor pi&#xF9; raramente &#xE8; riportato il coinvolgimento del distretto cervico-facciale. La diagnosi di tale affezione pu&#xF2; essere difficoltosa:
necessita sempre della conferma istologica.</p>
      </trans-abstract>
      <kwd-group>
        <title>KEY WORDS</title>
        <kwd>Head &amp; neck</kwd>
        <kwd>Paralateral nasal region</kwd>
        <kwd>Subcutaneous sarcoidosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="S1">
      <title>Introduction</title>
      <p>Subcutaneous sarcoidosis is a rare cutaneous expression
of systemic sarcoidosis <xref ref-type="bibr" rid="R01"><sup>1</sup></xref>.</p>
      <p>Sarcoidosis is a multisystem disorder characterized by the
formation of non-caseating granulomas. It is reported to be
caused by an oligoclonal response of CD4-positive T cells
to an unknown antigen <xref ref-type="bibr" rid="R02"><sup>2</sup></xref>. The disorder may be manifested
in numerous ways. In 90% of the patients, intra-thoracic
involvement is revealed on chest radiography. Other frequently
involved sites are the reticulo-endothelial system,
the skin, and the eye. Sarcoidosis can also affect joints,
muscles, exocrine and endocrine glands, the heart, the
central nervous system, the upper respiratory tract, and
the kidney <xref ref-type="bibr" rid="R02"><sup>2</sup></xref>.</p>
      <p>Subcutaneous sarcoidosis is characterized by non-infectious
sarcoidal or epithelioid granulomas with minimal
lymphocytic inflammation involving predominantly the
panniculus. Subcutaneous involvement, over the extremities,
occurs primarily in 20-35% of patients with systemic
sarcoidosis, but may also occur without systemic disease.
Histological assessment is mandatory for a definitive diagnosis
<xref ref-type="bibr" rid="R03"><sup>3</sup></xref>.</p>
      <p>The rare case of subcutaneous sarcoidosis with paralateral
nasal involvement is presented.</p>
    </sec>
    <sec id="S2">
      <title>Case report</title>
      <p>A 38-year-old female was addressed to the ENT Department
of the University Hospital of Ferrara for the assessment
of a subcutaneous right paralateral nasal mass, also
involving the suborbital region.</p>
      <p>The patient had been complaining of a swelling in her
right paralateral nasal region, associated with recurrent
frontal headache, for 3 months. She had already been
treated with systemic steroids (prednisone 25 mg/die for
3 weeks) and antibiotics (ciprofloxacin 500 mg/die for 10
days), which were unsuccessfull. Computed tomography
(CT) scans and magnetic resonance imaging (MRI) of the
paranasal sinuses were performed (<xref ref-type="fig" rid="F1">Fig. 1</xref>), disclosing a
subcutaneous mass, about 1 cm in diameter, at the inferior
edge of the right nasal bone.</p>
      <fig fig-type="Halftone" id="F1" position="float">
        <label>Fig. 1.</label>
        <caption>
          <p>The paranasal sinuses CT (a) and MRI (b) scans revealed a subcutaneous mass about 1 cm in diameter, located at the inferior edge of the right nasal
bone. Right nasal bone erosion can be detected at CT.</p>
        </caption>
        <graphic xlink:href="0392-100X-31-118-g001"/>
      </fig>
      <p>Her past medical history revealed histological diagnosis
of erythema nodosum (EN) (right leg), when she was
aged 21 years. She underwent an open septo/rhinoplasty
when she was 33 (in another hospital).</p>
      <p>At the examination, the lesion appeared nodular, non-tender,
firm and painful, in the right paralateral nasal region.
Serological testing for syphilis, anti-neutrophil cytoplasmatic
antibodies, and antinuclear antibodies all resulted
negative. Serum angiotensin-converting enzyme (ACE) was mildly elevated (85 nmol/ml; reference: 23-67 nmol/
ml). No other cutaneous or extra-cutaneous lesions were
present and/or documented, in particular, chest X-ray and
pulmonary CT scans were normal. Fundoscopy also revealed
no abnormalities.</p>
      <p>A fine needle aspiration biopsy (FNAB) was promptly
performed, but the cytological result was not conclusive
(documented "aspecific cells"). The mass was then excised
under general anaesthesia through a paralatero-nasal
approach. Upon reaching the subperiosteal plane, the
lesion was gradually isolated, as the presence of a pseudocapsule
facilitated the separation of the mass from the surrounding
tissue. The mass was then removed.</p>
      <p>The histological analysis indicated sarcoidosis; it revealed
a nodular inflammatory mass limited to the subcutaneous
tissue, composed of epithelioid granulomas, few giant
cells and hyalinosis. Stains and cultures for mycobacteria
and fungi were negative (<xref ref-type="fig" rid="F2">Fig. 2</xref>).</p>
      <fig fig-type="Halftone" id="F2" position="float">
        <label>Fig. 2.</label>
        <caption>
          <p>In the specimen epithelioid cells together with multinucleate giant
cells are visible. There are no signs of necrosis or of lymphocyte infiltration
(H&amp;E, x250).</p>
        </caption>
        <graphic xlink:href="0392-100X-31-118-g002"/>
      </fig>
      <p>The patient was addressed to the Rheumatology Unit
where she was treated with prednisone 12.5 mg/die and
this treatment has been maintained till now. After 30
months' of follow-up, no signs of local recurrence have
been observed (<xref ref-type="fig" rid="F3">Fig. 3</xref>) and, so far, no other localizations
of disease have been reported.</p>
      <fig fig-type="Halftone" id="F3" position="float">
        <label>Fig. 3.</label>
        <caption>
          <p>At CT scan performed after 30 months of follow-up, no sign of local
recurrence has been observed, while the profile of the right nasal bone
is almost normal.</p>
        </caption>
        <graphic xlink:href="0392-100X-31-118-g003"/>
      </fig>
    </sec>
    <sec id="S3">
      <title>Discussion and conclusions</title>
      <p>Sarcoidosis is a multisystem disease defined by the formation
of non-caseating granulomas in various organs.
The diagnosis is well established when clinical and radiological
findings are supported by histological evidence
of non-caseating granulomas in one or more tissues <xref ref-type="bibr" rid="R04"><sup>4</sup></xref>.
Subcutaneous involvement occurs in 20-35% of patients
with systemic sarcoidosis but may also occur alone without
systemic disease <xref ref-type="bibr" rid="R01"><sup>1</sup></xref>. Subcutaneous sarcoidosis alone is
defined as a rare manifestation of sarcoidosis <xref ref-type="bibr" rid="R01"><sup>1</sup></xref>. Darier and
Roussy reported the first case of subcutaneous sarcoidosis
in 1904 <xref ref-type="bibr" rid="R05"><sup>5</sup></xref>. Vainsencher and Winkelmann, in 1984, reported 4 cases of subcutaneous sarcoidosis, 3 of which showed
systemic involvement <xref ref-type="bibr" rid="R01"><sup>1</sup></xref>. It is reported to occur mainly in
women, most often in their fifth or sixth decades <xref ref-type="bibr" rid="R06"><sup>6</sup></xref>.</p>
      <p>The diagnosis of subcutaneous sarcoidosis is difficult to
achieve and can only be confirmed by histological studies.
Various non-specific laboratory abnormalities may be
seen, such as an elevated erythrocyte sedimentation rate
and hyper-gamma-globulinaemia <xref ref-type="bibr" rid="R02"><sup>2</sup></xref>. An elevated serum
angiotensin-converting enzyme (ACE) level is reported
to have a sensitivity of 40-90% and a positive predictive
value of up to 90% but may be falsely positive in several
other granulomatous diseases, hyperthyroidism, liver cirrhosis,
diabetes mellitus, and Gaucher's disease. Furthermore,
it may be falsely negative when ACE inhibitors are
used <xref ref-type="bibr" rid="R02"><sup>2</sup></xref> <xref ref-type="bibr" rid="R07"><sup>7</sup></xref>. Other reported laboratory abnormalities include
hypercalcaemia and hypercalciuria (2-63%) <xref ref-type="bibr" rid="R02"><sup>2</sup></xref>. A specific
diagnostic test is the Kveim-Siltzbach skin test that has
a reported sensitivity of 30-96% and is not widely used <xref ref-type="bibr" rid="R02"><sup>2</sup></xref>.
The histological assessment is mandatory for a definitive
diagnosis <xref ref-type="bibr" rid="R03"><sup>3</sup></xref>, as in the case presented here.</p>
      <p>The association between subcutaneous sarcoidosis and
EN, as in this case, is not frequently reported and some
Authors describe the occurrence of EN as a first manifestation
of immunologic disease <xref ref-type="bibr" rid="R08"><sup>8</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R10"><sup>10</sup></xref>.</p>
      <p>Moreover, the present case report illustrates a rare localization
of subcutaneous sarcoidosis, as the nodules are
mainly distributed over the extremities (upper extremities,
mainly in the forearms, and usually are bilateral and
asymmetric) and rarely on the trunk and face <xref ref-type="bibr" rid="R08"><sup>8</sup></xref> <xref ref-type="bibr" rid="R11"><sup>11</sup></xref>.</p>
      <p>Differential diagnosis includes lipoma, lupus vulgaris, leprosy,
rosacea, granuloma, reaction to foreign bodies <xref ref-type="bibr" rid="R09"><sup>9</sup></xref> <xref ref-type="bibr" rid="R12"><sup>12</sup></xref>.</p>
      <p>At present, there is no curative treatment for sarcoidosis.
Immunosuppressive and/or immunomodulatory drugs,
however, are used for controlling the disease, with corticosteroids
remaining the mainstay of treatment. They
function by suppressing the pro-inflammatory cytokines
and chemokines that are involved in cell-mediated immune
responses and granuloma formation. Methotrexate
or hydroxychloroquine may be added, especially if the response
to steroids is inadequate. Although the chemokine
and cytokine pathways that regulate granuloma formation
are not well understood, tumour necrosis factor-alpha
(TNF&#x3B1;) is implicated. TNF&#x3B1; antagonists such as pentoxifylline
and thalidomide are reported to be useful in refractory
systemic disease and neurosarcoidosis. Infliximab (a
monoclonal antibody against TNF&#x3B1;) in particular has a
growing body of literature supporting its effectiveness,
and appears to be a safe treatment approach with a good
steroid-sparing effect <xref ref-type="bibr" rid="R13"><sup>13</sup></xref> <xref ref-type="bibr" rid="R14"><sup>14</sup></xref>.</p>
      <p>In the case reported here, the paralateral nasal nodule was
the only one that occurred, and the long-term treatment with
steroids seems to be effective in controlling the disease.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R01">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vainsencher</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Winkelmann</surname>
              <given-names>RK</given-names>
            </name>
          </person-group>
          <article-title>Subcutaneous sarcoidosis</article-title>
          <source>Arch Dermatol</source>
          <year>1984</year>
          <volume>120</volume>
          <fpage>1028</fpage>
          <lpage>1031</lpage>
          <pub-id pub-id-type="pmid">6465908</pub-id>
        </element-citation>
      </ref>
      <ref id="R02">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bauer</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Brouwer</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Smit</surname>
              <given-names>VT</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The challenges of extrapulmonary
presentations of sarcoidosis: A case report and
review of diagnostic strategies</article-title>
          <source>Eur J Int Med</source>
          <year>2007</year>
          <volume>18</volume>
          <fpage>152</fpage>
          <lpage>154</lpage>
        </element-citation>
      </ref>
      <ref id="R03">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kerner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ziv</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Abu-Raya</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Subcutaneous sarcoidosis
with neurological involvement: an unusual combination</article-title>
          <source>Isr Med Assoc J</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>428</fpage>
          <lpage>430</lpage>
          <pub-id pub-id-type="pmid">18669139</pub-id>
        </element-citation>
      </ref>
      <ref id="R04">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hunninghake</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Costabel</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Ando</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ATS/ERS/
WASOG statement on sarcoidosis</article-title>
          <source>Sarcoidosis Vasc Diffuse
Lung Dis</source>
          <year>1999</year>
          <volume>16</volume>
          <fpage>149</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="pmid">10560120</pub-id>
        </element-citation>
      </ref>
      <ref id="R05">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darier</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Roussy</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Des sarco&#xEF;des sous-cutan&#xE9;es. Contribution
&#xE0; l'&#xE9;tude des tuberculides ou tuberculoses attenu&#xE9;es de
l'hypoderme</article-title>
          <source>Ann Dermatol Syphilol</source>
          <year>1904</year>
          <volume>5</volume>
          <fpage>144</fpage>
          <lpage>149</lpage>
        </element-citation>
      </ref>
      <ref id="R06">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Higgins</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Salisbury</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Vivier</surname>
              <given-names>AWP</given-names>
              <prefix>Du</prefix>
            </name>
          </person-group>
          <article-title>Subcutaneous
sarcoidosis</article-title>
          <source>Clin Exp Dermatol</source>
          <year>1993</year>
          <volume>18</volume>
          <fpage>65</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">8440058</pub-id>
        </element-citation>
      </ref>
      <ref id="R07">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costabel</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Teschle</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Biochemical changes in sarcoidosis</article-title>
          <source>Clin Chest Med</source>
          <year>1997</year>
          <volume>18</volume>
          <fpage>827</fpage>
          <lpage>842</lpage>
          <pub-id pub-id-type="pmid">9413661</pub-id>
        </element-citation>
      </ref>
      <ref id="R08">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcoval</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mana</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Subcutaneous sarcoidosis
clinicopathological study of 10 cases</article-title>
          <source>Br J Derm</source>
          <year>2005</year>
          <volume>153</volume>
          <fpage>790</fpage>
          <lpage>794</lpage>
        </element-citation>
      </ref>
      <ref id="R09">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcoval</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Moreno</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mana</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Subcutaneous sarcoidosis</article-title>
          <source>Dermatol Clin</source>
          <year>2008</year>
          <volume>26</volume>
          <fpage>553</fpage>
          <lpage>556</lpage>
          <pub-id pub-id-type="pmid">18793989</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajoriya</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wotton</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Yeates</surname>
              <given-names>DG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immune-mediated
and chronic inflammatory disease in people with sarcoidosis:
disease associations in a large UK database</article-title>
          <source>Postgrad
Med J</source>
          <year>2009</year>
          <volume>85</volume>
          <fpage>233</fpage>
          <lpage>237</lpage>
          <pub-id pub-id-type="pmid">19520873</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalb</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Grossman</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Sarcoidosis with subcutaneous
nodules</article-title>
          <source>Am J Med</source>
          <year>1988</year>
          <volume>85</volume>
          <fpage>731</fpage>
          <lpage>736</lpage>
          <pub-id pub-id-type="pmid">3189377</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fuchs</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Tanner</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>Granulomatous disorders of the nose
and paranasal sinuses</article-title>
          <source>Curr Opin Otolaryngol Head Neck
Surg</source>
          <year>2009</year>
          <volume>17</volume>
          <fpage>23</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">19225301</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Callejas-Rubio</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez-P&#xE9;rez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ortego-Centeno</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Tumor
necrosis factor-alpha inhibitor treatment for sarcoidosis</article-title>
          <source>Ther Clin Risk Manag</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>1305</fpage>
          <lpage>1313</lpage>
          <pub-id pub-id-type="pmid">19337437</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sweiss</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Curran</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Baughman</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>Sarcoidosis, role of tumor
necrosis factor inhibitors and other biologic agents, past,
present, and future concepts</article-title>
          <source>Clin Dermatol</source>
          <year>2007</year>
          <volume>25</volume>
          <fpage>341</fpage>
          <lpage>346</lpage>
          <pub-id pub-id-type="pmid">17560312</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
